Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes

Medicine & Life Sciences

• pramlintide 85%
• Islet Amyloid Polypeptide 52%
• Type 1 Diabetes Mellitus 44%
• Type 2 Diabetes Mellitus 37%
• Insulin 21%
• Nausea 11%
• Neurotransmitter Agents 10%
• Drug Information Services 10%
• Therapeutics 8%
• Clinical Trials 8%
• Glucose 7%
• Gastric Emptying 7%
• Metformin 6%
• Glucagon 6%
• United States Food and Drug Administration 6%
• Contraindications 6%
• Drug Interactions 6%
• Hypoglycemia 6%
• Meals 5%
• MEDLINE 5%
• Pancreas 5%
• Blood Glucose 5%
• Weight Loss 5%
• Fasting 4%
• Language 4%
• Eating 4%
• Pharmacokinetics 4%
• Amino Acids 4%
• Pharmacology 4%
• Peptides 3%
• Databases 3%
• Safety 3%
• Serum 2%
• Pharmaceutical Preparations 2%

Chemical Compounds

• Pramlintide 100%
• Amylin 67%
• Insulin Derivative 36%
• Neurohormone 23%
• Glucose 15%
• Metformin 10%
• Glucagon 9%
• Drug 7%
• Safety 6%
• Pharmacokinetics 5%
• Pharmaceutical 5%
• Food 5%
• Peptide 4%
• Weight 3%
• Reduction 3%
• Acid 2%